The U.S. partner SK Biopharma is given an EMA sleepiness node.

SK Biopharmaceuticals is a global pharmaceutical company that develops new medicines to support medical innovation. As part of our quest for the SK Group next-generation rising engine, SK Biopharmaceuticals started to research and the development of new drugs in 1993. The spirited rise of SK Biop...

Bayer aims to increase the emphasis on research and development, creativity

According to a top company official, Bayer Pharmaceuticals sees great potential in the Chinese market for promoting innovation and digitalization and has listed China as one of its priorities.

The company's chairman, Stefan Oelrich, said it has a specific strength role in China that...